Abstract
Recent studies identified variants of the Infectious bronchitis vírus (IBV) exclusives from Brazil (BR), which genotype is not related to the Massachussets serotype. In Brazil, alive vaccines for IBV are only allowed if belonging to this serotype, what suggests an inefficient protection against brazilian variants. Due to the lack of studies focusing the pathogenicity of the BR variant of …